Bantam Pharmaceutical, LLC
8Patents
7Active
8Granted
42Portfolio score
Filing activity: Oct 22, 2013 → May 29, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10537558B2 | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto | Chemistry; Metallurgy | 3 | Active |
| US12150934B2 | Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases | Human Necessities | 0 | Active |
| US11602526B2 | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto | Chemistry; Metallurgy | 0 | Active |
| US11325903B2 | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases | Chemistry; Metallurgy | 0 | Active |
| US11192887B2 | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases | General | 0 | Revoked |
| US12378234B2 | Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative | Chemistry; Metallurgy | 0 | Active |
| US12358905B2 | Methods for making thiazolypyrazole carboxylic acids and intermediates therefor | Human Necessities | 0 | Active |
| US9409901B2 | Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.